Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled date : 2021 - 10 - 20 save search
FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma
Published: 2021-10-20 (Crawled : 22:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.41%
C: 0.41%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 0.31%
H: 1.14%
C: 0.87%
fda children approval dupixent
Magellan Midstream Increases Quarterly Cash Distribution to $1.0375, Announces Completion of Previous Equity Repurchase Program and Approval of Additional $750 Million Authorization
Published: 2021-10-20 (Crawled : 21:00) - prnewswire.com
MMP | $69.0 0.67% 0.0% 31M
|
Industrial Services
|
| O: 2.64%
H: 0.53%
C: -0.77%
distribution approval
LumiraDx receives approval for its COVID-19 Antigen Test for use in India
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: 20.4%
H: 3.25%
C: -6.7%
covid test india approval covid-19
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 2.37%
H: 0.65%
C: -0.3%
treatment russia brukinsa approval
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.